Tecentriq IV infusion 1200mg contains atezolizumab (genetical recombination) and is manufactured by Chugai Pharmaceutical. This injectable drug (YJ code: 4291441A1024) is provided as 1,200mg in 20mL per bottle and is used in the treatment of various cancers, including non-small cell lung cancer, small cell lung cancer, and hepatocellular carcinoma.
Tecentriq IV infusion 1200mg
Need more detailed information?
Contact TASAKI PHARMA for product sourcing, availability, or related support (English support available).